DGK-IN-8
DGK-IN-8 (Example 34) is a DGK inhibitor, with IC50 of ≤ 20 nM for DGKα and ζ. DGK-IN-8 can be used for cancer research[1].
Product Specifications
CAS Number
[3039488-69-9]
UNSPSC
12352005
Target
DGK
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
FC(F)(C1=C(N2CC3(CCC2)CCN(CC3)CC4CC4)C(/C=C(C5=NC(N6CC(F)(C6)F)=CN=C5)\F)=CC=C1OC7=CC=CC=C7)F
Molecular Formula
C35H37F6N5O
Molecular Weight
657.69
References & Citations
[1]Ming Xiang, et al. Heteroaryl fluoroalkenes as dgk inhibitors. Patent. WO2024108100
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
A0859-35H 100 µg
ADAM 17, CT (ADAM17, A Disintegrin and Metalloproteinase Domain 17 (Tumor Necrosis Factor, alpha, Converting Enzyme), CSVP, TACE, cSVP, CD156b, CD156b, MGC71942, TACE, cSVPADAM Metallopeptidase Domain 17, TNF-alpha Converting Enzyme, A Disintegrin and Metalloproteinase Domain 17, A Disintegrin and Metalloproteinase Domain 17 (Tumor Necrosis Factor, alpha, Converting Enzyme), Snake Venom-like Protease)
Sign In for Pricing
View Details 
GTR15144385 1 Vial
Lentiviral mouse Vmn1r56 shRNA (UAS) - Lentiviral mouse Vmn1r56 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
3B1258 48 Reactions
TRUPCR® PML-RARA Qualitative PCR Test (BCR1, BCR2, BCR3)
Sign In for Pricing
View Details 